Scholars Central

Conference abstractPublished 16 Oct 2015

Changes in liver metabolism in Mg2+ deficiency: Implications for NAFLD and metabolic syndrome

Authors: Andrea M P Romani, Chesinta Voma, Lauren Keenan, Coleen Croniger, Michelle Puckowic

Case Western Reserve University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Metabolic Syndrome, a pathological condition affecting approximately one-third of the USA population, is characterized by obesity, hepatic steatosis, insulin resistance, and hypertension among other medical conditions, and represents the single most common condition predisposing to diabetes and hypertension. Within this contest, liver steatosis is considered the hepatic representation of the disease and is currently classified as NAFLD. Hypomagnesaemia has been consistently observed in association with metabolic syndrome, and recent data from our laboratory suggest low Mg2+ level in the circulation and within the hepatocytes promotes dysmetabolic conditions typical of the metabolic syndrome. Rats exposed for 2 weeks to a 40% Mg2+ deficient diet present a 2-3 fold increase in intrahepatic triglyceride content associated with a marked increase in numerous genes involved in fatty acid synthesis including IRS2, SREBP1c, PPARÃ?³, FAS, LCAD, HMG-CoA reductase and HMG-CoA synthethase. PPAR-Ã?±, instead remained unaltered. The upregulation of IRS2 contrasted the downregulation of IRS- 1 and pAkt, leading to decreased glucose accumulation, and attenuated insulin signaling. As a result of this altered signaling Fox-01 remained active and resulted in the upregulation of the gluconeogenic genes PEPCK and F, 16 BPase. Additionally, the reticular hexose 6-phosphate dehydrogenase (H6PD) and the coupled 11Ã?²-hydroxysteroid dehydrogenase-1 (11-Ã?²-HSD1) were both 3-4 fold upregulated in gene and protein expression, resulting in the significant production of intraluminal NADPH and cortisol levels. Taken together, our results provide compelling evidence that reduced extracellular Mg2+ level precedes and promotes metabolic syndrome onset in that: 1) liver metabolism undergoes a switch from glucose-based to fatty acidbased synthesis with minimal changes in catabolism, resulting in the increased deposition of intrahepatic triglycerides; 2) increased cortisol production, and 3) reduced insulin responsiveness. The majority of these gene dysregulation trended towards renormalization following the restoration of normal extracellular and cellular Mg2+ content.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Obesity & Weight Loss Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Obesity & Weight Loss Therapy
  • SubjectObesity & Weight Management
  • BylineArticles whose byline prints “Andrea M P Romani”
  • BylineArticles whose byline prints “Chesinta Voma”
  • BylineArticles whose byline prints “Lauren Keenan”
  • BylineArticles whose byline prints “Coleen Croniger”
  • BylineArticles whose byline prints “Michelle Puckowic”